- Home
- FHTX vs FRBA Comparison
FHTX vs FRBA Comparison
Compare FHTX & FRBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FHTX | FRBA |
|---|---|---|
| Founded | 2015 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 360.8M | 377.6M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | FHTX | FRBA |
|---|---|---|
| Price | $5.46 | $17.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | $11.67 | ★ $19.00 |
| AVG Volume (30 Days) | ★ 165.9K | 70.8K |
| Earning Date | 03-05-2026 | 01-26-2026 |
| Dividend Yield | N/A | ★ 2.08% |
| EPS Growth | N/A | ★ 4.19 |
| EPS | N/A | ★ 1.74 |
| Revenue | $24,518,000.00 | ★ $135,310,000.00 |
| Revenue This Year | $40.91 | $14.06 |
| Revenue Next Year | $11.87 | $5.86 |
| P/E Ratio | ★ N/A | $9.93 |
| Revenue Growth | N/A | ★ 5.16 |
| 52 Week Low | $2.95 | $12.74 |
| 52 Week High | $6.95 | $18.11 |
Technical Indicators
Market Signals| Indicator | FHTX | FRBA |
|---|---|---|
| Relative Strength Index (RSI) | 48.10 | 56.93 |
| Support Level | $5.11 | $17.02 |
| Resistance Level | $5.79 | $17.52 |
| Average True Range (ATR) | 0.34 | 0.47 |
| MACD | -0.08 | 0.03 |
| Stochastic Oscillator | 38.20 | 77.50 |
Price Performance
Historical ComparisonAbout FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.
About FRBA First Bank
First Bank is a full-service commercial bank, with target businesses from individuals, businesses, and governmental entities located in service regions throughout New Jersey and eastern Pennsylvania, with a particular focus between New York City and Philadelphia. The group focuses on traditional deposit and loan products with businesses and individuals living and working in markets as the source of businesses. Its services are Business Banking; Personal banking; Digital Banking; and Lending.